Skip to main content Accessibility help
×
Home
  • Print publication year: 2019
  • Online publication date: October 2019

Chapter 7 - Distinctive Constellations and Other Epilepsies

Summary

The International League Against Epilepsy recently published an updated classification that better reflects our understanding of epilepsies and their mechanisms.1 This chapter discusses specific epilepsy syndromes, epilepsies that are not associated with a specific age of onset, reflex epilepsies, and the main etiologic groups described in the updated classification, including structural, genetic, infectious, metabolic, and immune mediated.

Related content

Powered by UNSILO
1.Scheffer, IE, Berkovic, S, Capovilla, G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512521.
2.de Lanerolle, NC, Kim, JH, Williamson, A, et al. A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories. Epilepsia. 2003;44(5):677687.
3.Noulhiane, M, Samson, S, Clemenceau, S, et al. A volumetric MRI study of the hippocampus and the parahippocampal region after unilateral medial temporal lobe resection. J Neurosci Methods. 2006;156(1-2):293304.
4.Asadi-Pooya, AA, Stewart, GR, Abrams, DJ, Sharan, A. Prevalence and incidence of drug-resistant mesial temporal lobe epilepsy in the United States. World Neurosurg. 2017;99:662666.
5.Helmstaedter, C, Kurthen, M, Lux, S, Reuber, M, Elger, CE. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol. 2003;54(4):425432.
6.Gomez-Ibanez, A, Gasca-Salas, C, Urrestarazu, E, Viteri, C. Clinical phenotypes within non-surgical patients with mesial temporal lobe epilepsy caused by hippocampal sclerosis based on response to antiepileptic drugs. Seizure. 2013;22(1):2023.
7.Engel, J Jr., Williamson, PD, Wieser, HG. Medial temporal lobe epilepsy with hippocampal sclerosis. In: Engel, J, Pedley, TA, eds., Epilepsy: A Comprehensive Textbook. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:24792486.
8.Wieser, HG, Epilepsy, ICoNo. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia. 2004;45(6):695714.
9.Ferrari-Marinho, T, Caboclo, LO, Marinho, MM, et al. Auras in temporal lobe epilepsy with hippocampal sclerosis: relation to seizure focus laterality and post surgical outcome. Epilepsy Behav. 2012;24(1):120125.
10.Palmini, AL, Gloor, P, Jones-Gotman, M. Pure amnestic seizures in temporal lobe epilepsy. Definition, clinical symptomatology and functional anatomical considerations. Brain. 1992;115(Pt 3):749769.
11.Kotagal, P, Bleasel, A, Geller, E, et al. Lateralizing value of asymmetric tonic limb posturing observed in secondarily generalized tonic-clonic seizures. Epilepsia. 2000;41(4):457462.
12.Loddenkemper, T, Kotagal, P. Lateralizing signs during seizures in focal epilepsy. Epilepsy Behav. 2005;7(1):117.
13.Privitera, MD, Morris, GL, Gilliam, F. Postictal language assessment and lateralization of complex partial seizures. Ann Neurol. 1991;30(3):391396.
14.Geyer, JD, Payne, TA, Faught, E, Drury, I. Postictal nose-rubbing in the diagnosis, lateralization, and localization of seizures. Neurology. 1999;52(4):743745.
15.Cendes, F, Sakamoto, AC, Spreafico, R, Bingaman, W, Becker, AJ. Epilepsies associated with hippocampal sclerosis. Acta Neuropathol. 2014;128(1):2137.
16.Vanli-Yavuz, EN, Erdag, E, Tuzun, E, et al. Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis. J Neurol Neurosurg Psychiatry. 2016;87(7):684692.
17.Cendes, F, Andermann, F, Gloor, P, et al. Atrophy of mesial structures in patients with temporal lobe epilepsy: cause or consequence of repeated seizures? Ann Neurol. 1993;34(6):795801.
18.Thom, M. Review: hippocampal sclerosis in epilepsy. A neuropathology review. Neuropathol Appl Neurobiol. 2014;40(5):520543.
19.Blumcke, I, Thom, M, Aronica, E, et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a task force report from the ILAE Commission on Diagnostic Methods. Epilepsia. 2013;54(7):13151329.
20.Blumcke, I, Pauli, E, Clusmann, H, et al. A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol. 2007;113(3):235244.
21.Jardim, AP, Neves, RS, Caboclo, LO, et al. Temporal lobe epilepsy with mesial temporal sclerosis: hippocampal neuronal loss as a predictor of surgical outcome. Arq Neuropsiquiatr. 2012;70(5):319324.
22.Tezer, FI, Xasiyev, F, Soylemezoglu, F, et al. Clinical and electrophysiological findings in mesial temporal lobe epilepsy with hippocampal sclerosis, based on the recent histopathological classifications. Epilepsy Res. 2016;127:5054.
23.Sirin, NG, Gurses, C, Bebek, N, et al. A quadruple examination of ictal EEG patterns in mesial temporal lobe epilepsy with hippocampal sclerosis: onset, propagation, later significant pattern, and termination. J Clin Neurophysiol. 2013;30(4):329338.
24.Reiher, J, Beaudry, M, Leduc, CP. Temporal intermittent rhythmic delta activity (TIRDA) in the diagnosis of complex partial epilepsy: sensitivity, specificity and predictive value. Can J Neurol Sci. 1989;16(4):398401.
25.Dericioglu, N, Saygi, S. Ictal scalp EEG findings in patients with mesial temporal lobe epilepsy. Clin EEG Neurosci. 2008;39(1):2027.
26.Jones, AL, Cascino, GD. Evidence on use of neuroimaging for surgical treatment of temporal lobe epilepsy: a systematic review. JAMA Neurol. 2016;73(4):464470.
27.Azab, M, Carone, M, Ying, SH, Yousem, DM. Mesial temporal sclerosis: accuracy of NeuroQuant versus neuroradiologist. Am J Neuroradiol. 2015;36(8):14001406.
28.Rudie, JD, Colby, JB, Salamon, N. Machine learning classification of mesial temporal sclerosis in epilepsy patients. Epilepsy Res. 2015;117:6369.
29.Muhlhofer, W, Tan, YL, Mueller, SG, Knowlton, R. MRI-negative temporal lobe epilepsy – what do we know? Epilepsia. 2017; 58(5):727742.
30.Guedj, E, Bonini, F, Gavaret, M, et al. 18FDG-PET in different subtypes of temporal lobe epilepsy: SEEG validation and predictive value. Epilepsia. 2015;56(3):414421.
31.Lee, EM, Im, KC, Kim, JH, et al. Relationship between hypometabolic patterns and ictal scalp EEG patterns in patients with unilateral hippocampal sclerosis: an FDG-PET study. Epilepsy Res. 2009;84(2–3):187193.
32.Dupont, S, Semah, F, Clemenceau, S, et al. Accurate prediction of postoperative outcome in mesial temporal lobe epilepsy: a study using positron emission tomography with 18fluorodeoxyglucose. Arch Neurol. 2000;57(9):13311336.
33.Chassoux, F, Artiges, E, Semah, F, et al. 18F-FDG-PET patterns of surgical success and failure in mesial temporal lobe epilepsy. Neurology. 2017;88(11):10451053.
34.Wong, CH, Bleasel, A, Wen, L, et al. The topography and significance of extratemporal hypometabolism in refractory mesial temporal lobe epilepsy examined by FDG-PET. Epilepsia. 2010;51(8):13651373.
35.Daly, DD, Mulder, DW. Gelastic epilepsy. Neurology. 1957;7(3):189192.
36.Striano, S, Santulli, L, Ianniciello, M, et al. The gelastic seizures-hypothalamic hamartoma syndrome: facts, hypotheses, and perspectives. Epilepsy Behav. 2012;24(1):713.
37.Kovac, S, Diehl, B, Wehner, T, et al. Gelastic seizures: incidence, clinical and EEG features in adult patients undergoing video-EEG telemetry. Epilepsia. 2015;56(1):e1–5.
38.Gutierrez, C, Asadi-Pooya, AA, Skidmore, CT, et al. Clinical features and postoperative seizure outcome in patients with drug-resistant gelastic seizures without hypothalamic hamartoma. Epilepsy Behav. 2016;64(Pt A):9093.
39.Striano, S, Meo, R, Bilo, L, et al. Gelastic epilepsy: symptomatic and cryptogenic cases. Epilepsia. 1999;40(3):294302.
40.Craig, DW, Itty, A, Panganiban, C, et al. Identification of somatic chromosomal abnormalities in hypothalamic hamartoma tissue at the GLI3 locus. Am J Hum Genet. 2008;82(2):366374.
41.Kerrigan, JF, Ng, YT, Chung, S, Rekate, HL. The hypothalamic hamartoma: a model of subcortical epileptogenesis and encephalopathy. Semin Pediatr Neurol. 2005;12(2):119131.
42.Brandberg, G, Raininko, R, Eeg-Olofsson, O. Hypothalamic hamartoma with gelastic seizures in Swedish children and adolescents. Eur J Paediatr Neurol. 2004;8(1):3544.
43.Weissenberger, AA, Dell, ML, Liow, K, et al. Aggression and psychiatric comorbidity in children with hypothalamic hamartomas and their unaffected siblings. J Am Acad Child Adolesc Psychiatry. 2001;40(6):696703.
44.Berkovic, SF, Kuzniecky, RI, Andermann, F. Human epileptogenesis and hypothalamic hamartomas: new lessons from an experiment of nature. Epilepsia. 1997;38(1):13.
45.Kahane, P, Ryvlin, P, Hoffmann, D, Minotti, L, Benabid, AL. From hypothalamic hamartoma to cortex: what can be learnt from depth recordings and stimulation? Epileptic Disord. 2003;5(4):205217.
46.Palmini, A, Chandler, C, Andermann, F, et al. Resection of the lesion in patients with hypothalamic hamartomas and catastrophic epilepsy. Neurology. 2002;58(9):13381347.
47.DiFazio, MP, Davis, RG. Utility of early single photon emission computed tomography (SPECT) in neonatal gelastic epilepsy associated with hypothalamic hamartoma. J Child Neurol. 2000;15(6):414417.
48.Palmini, A, Van Paesschen, W, Dupont, P, Van Laere, K, Van Driel, G. Status gelasticus after temporal lobectomy: ictal FDG-PET findings and the question of dual pathology involving hypothalamic hamartomas. Epilepsia. 2005;46(8):13131316.
49.Ng, YT, Rekate, HL, Prenger, EC, et al. Transcallosal resection of hypothalamic hamartoma for intractable epilepsy. Epilepsia. 2006;47(7):11921202.
50.Rekate, HL, Feiz-Erfan, I, Ng, YT, Gonzalez, LF, Kerrigan, JF. Endoscopic surgery for hypothalamic hamartomas causing medically refractory gelastic epilepsy. Childs Nerv Syst. 2006;22(8):874880.
51.Berkovic, SF, Arzimanoglou, A, Kuzniecky, R, et al. Hypothalamic hamartoma and seizures: a treatable epileptic encephalopathy. Epilepsia. 2003;44(7):969973.
52.Quiske, A, Frings, L, Wagner, K, Unterrainer, J, Schulze-Bonhage, A. Cognitive functions in juvenile and adult patients with gelastic epilepsy due to hypothalamic hamartoma. Epilepsia. 2006;47(1):153158.
53.Striano, S, Striano, P, Coppola, A, Romanelli, P. The syndrome gelastic seizures-hypothalamic hamartoma: severe, potentially reversible encephalopathy. Epilepsia. 2009;50(Suppl 5):6265.
54.Arita, K, Ikawa, F, Kurisu, K, et al. The relationship between magnetic resonance imaging findings and clinical manifestations of hypothalamic hamartoma. J Neurosurg. 1999;91(2):212220.
55.Chibbaro, S, Cebula, H, Scholly, J, et al. Pure endoscopic management of epileptogenic hypothalamic hamartomas. Neurosurg Rev. 2017;40(4):647653.
56.Leal, AJ, Moreira, A, Robalo, C, Ribeiro, C. Different electroclinical manifestations of the epilepsy associated with hamartomas connecting to the middle or posterior hypothalamus. Epilepsia. 2003;44(9):11911195.
57.Kameyama, S, Shirozu, H, Masuda, H, et al. MRI-guided stereotactic radiofrequency thermocoagulation for 100 hypothalamic hamartomas. J Neurosurg. 2016;124(5):15031512.
58.Tellez-Zenteno, JF, Serrano-Almeida, C, Moien-Afshari, F. Gelastic seizures associated with hypothalamic hamartomas. An update in the clinical presentation, diagnosis and treatment. Neuropsychiatr Dis Treat. 2008;4(6):10211031.
59.Delalande, O, Fohlen, M. Disconnecting surgical treatment of hypothalamic hamartoma in children and adults with refractory epilepsy and proposal of a new classification. Neurol Med Chir (Tokyo). 2003;43(2):6168.
60.Valdueza, JM, Cristante, L, Dammann, O, et al. Hypothalamic hamartomas: with special reference to gelastic epilepsy and surgery. Neurosurgery. 1994;34(6):949958.
61.Berkovic, SF, Andermann, F, Melanson, D, et al. Hypothalamic hamartomas and ictal laughter: evolution of a characteristic epileptic syndrome and diagnostic value of magnetic resonance imaging. Ann Neurol. 1988;23(5):429439.
62.Troester, M, Haine-Schlagel, R, Ng, YT, et al. EEG and video-EEG seizure monitoring has limited utility in patients with hypothalamic hamartoma and epilepsy. Epilepsia. 2011;52(6):11371143.
63.Wu, J, Gao, M, Shen, JX, Qiu, SF, Kerrigan, JF. Mechanisms of intrinsic epileptogenesis in human gelastic seizures with hypothalamic hamartoma. CNS Neurosci Ther. 2015;21(2):104111.
64.Fenoglio, KA, Wu, J, Kim, DY, et al. Hypothalamic hamartoma: basic mechanisms of intrinsic epileptogenesis. Semin Pediatr Neurol. 2007;14(2):5159.
65.Coons, SW, Rekate, HL, Prenger, EC, et al. The histopathology of hypothalamic hamartomas: study of 57 cases. J Neuropathol Exp Neurol. 2007;66(2):131141.
66.Beggs, J, Nakada, S, Fenoglio, K, et al. Hypothalamic hamartomas associated with epilepsy: ultrastructural features. J Neuropathol Exp Neurol. 2008;67(7):657668.
67.Maixner, W. Hypothalamic hamartomas – clinical, neuropathological and surgical aspects. Childs Nerv Syst. 2006;22(8):867873.
68.Munari, C, Kahane, P, Francione, S, et al. Role of the hypothalamic hamartoma in the genesis of gelastic fits (a video-stereo-EEG study). Electroencephalogr Clin Neurophysiol. 1995;95(3):154160.
69.Rasmussen, T, Olszewski, J, Lloydsmith, D. Focal seizures due to chronic localized encephalitis. Neurology. 1958;8(6):435445.
70.Oguni, H, Andermann, F, Rasmussen, TB. The syndrome of chronic encephalitis and epilepsy: a study based on the MNI series of 48 cases. Adv Neurol. 1992;57:419433.
71.Pardo, CA, Nabbout, R, Galanopoulou, AS. Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES). Neurotherapeutics. 2014;11(2):297310.
72.Varadkar, S, Bien, CG, Kruse, CA, et al. Rasmussen’s encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol. 2014;13(2):195205.
73.Bien, CG, Granata, T, Antozzi, C, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain. 2005;128(Pt 3):454471.
74.Dubeau, F, Andermann, F, Wiendl, H, Bar-Or, A. Rasmussen’s encephalitis (chronic focal encephalitis). In: Engel, JJ, Pedley, TA, eds., Epilepsy: A Comprehensive Textbook. 2nd edn. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:24392453.
75.Bien, CG, Urbach, H, Deckert, M, et al. Diagnosis and staging of Rasmussen’s encephalitis by serial MRI and histopathology. Neurology. 2002;58(2):250257.
76.Granata, T, Gobbi, G, Spreafico, R, et al. Rasmussen’s encephalitis: early characteristics allow diagnosis. Neurology. 2003;60(3):422425.
77.Ramesha, KN, Rajesh, B, Ashalatha, R, et al. Rasmussen’s encephalitis: experience from a developing country based on a group of medically and surgically treated patients. Seizure. 2009;18(8):567572.
78.Avbersek, A, Miserocchi, A, McEvoy, AW, et al. Multiphasic presentation of Rasmussen’s encephalitis. Epileptic Disord. 2015;17(3):315320.
79.Press, C, Wallace, A, Chapman, KE. The Janus-faced nature of Rasmussen’s encephalitis. Semin Pediatr Neurol. 2014;21(2):129136.
80.Muto, A, Oguni, H, Takahashi, Y, et al. Nationwide survey (incidence, clinical course, prognosis) of Rasmussen’s encephalitis. Brain Dev. 2010;32(6):445453.
81.Casciato, S, Di Bonaventura, C, Fattouch, J, et al. Extrarolandic electroclinical findings in the evolution of adult-onset Rasmussen’s encephalitis. Epilepsy Behav. 2013;28(3):467473.
82.Gambardella, A, Andermann, F, Shorvon, S, Le Piane, E, Aguglia, U. Limited chronic focal encephalitis: another variant of Rasmussen syndrome? Neurology. 2008;70(5):374377.
83.Guan, Y, Luan, G, Zhou, J, Liu, X. Bilateral Rasmussen encephalitis. Epilepsy Behav. 2011;20(2):398403.
84.Tobias, SM, Robitaille, Y, Hickey, WF, et al. Bilateral Rasmussen encephalitis: postmortem documentation in a five-year-old. Epilepsia. 2003;44(1):127130.
85.Frucht, S. Dystonia, athetosis, and epilepsia partialis continua in a patient with late-onset Rasmussen’s encephalitis. Mov Disord. 2002;17(3):609612.
86.Takei, H, Wilfong, A, Malphrus, A, et al. Dual pathology in Rasmussen’s encephalitis: a study of seven cases and review of the literature. Neuropathology. 2010;30(4):381391.
87.Longaretti, F, Dunkley, C, Varadkar, S, et al. Evolution of the EEG in children with Rasmussen’s syndrome. Epilepsia. 2012;53(9):15391545.
88.So, N, Gloor, P. Electroencephalographic and electrocorticographic findings in chronic encephalitis of the Rasmussen type. In: Andermann, F, ed., Chronic Encephalitis and Epilepsy Rasmussen’s Syndrome. Stoneham, MA: Butterworth-Heinemann; 1991:3745.
89.Pardo, CA, Vining, EP, Guo, L, et al. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia. 2004;45(5):516526.
90.Bauer, J, Elger, CE, Hans, VH, et al. Astrocytes are a specific immunological target in Rasmussen’s encephalitis. Ann Neurol. 2007;62(1):6780.
91.Chiapparini, L, Granata, T, Farina, L, et al. Diagnostic imaging in 13 cases of Rasmussen’s encephalitis: can early MRI suggest the diagnosis? Neuroradiology. 2003;45(3):171183.
92.Yamazaki, E, Takahashi, Y, Akasaka, N, Fujiwara, T, Inoue, Y. Temporal changes in brain MRI findings in Rasmussen syndrome. Epileptic Disord. 2011;13(3):229239.
93.Bhatjiwale, MG, Polkey, C, Cox, TC, Dean, A, Deasy, N. Rasmussen’s encephalitis: neuroimaging findings in 21 patients with a closer look at the basal ganglia. Pediatr Neurosurg. 1998;29(3):142148.
94.Cauley, KA, Burbank, HN, Filippi, CG. Diffusion tensor imaging and tractography of Rasmussen encephalitis. Pediatr Radiol. 2009;39(7):727730.
95.Wagner, J, Schoene-Bake, JC, Bien, CG, et al. Automated 3D MRI volumetry reveals regional atrophy differences in Rasmussen encephalitis. Epilepsia. 2012;53(4):613621.
96.Fiorella, DJ, Provenzale, JM, Coleman, RE, Crain, BJ, Al-Sugair, AA. (18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. Am J Neuroradiol. 2001;22(7):12911299.
97.Shetty-Alva, N, Novotny, EJ, Shetty, T, Kuo, PH. Positron emission tomography in Rasmussen’s encephalitis. Pediatr Neurol. 2007;36(2):112114.
98.Scheffer, IE, Phillips, HA, O’Brien, CE, et al. Familial partial epilepsy with variable foci: a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann Neurol. 1998;44(6):890899.
99.Berkovic, SF, Serratosa, JM, Phillips, HA, et al. Familial partial epilepsy with variable foci: clinical features and linkage to chromosome 22q12. Epilepsia. 2004;45(9):10541060.
100.Klein, KM, O’Brien, TJ, Praveen, K, et al. Familial focal epilepsy with variable foci mapped to chromosome 22q12: expansion of the phenotypic spectrum. Epilepsia. 2012;53(8):e151–155.
101.Dibbens, LM, de Vries, B, Donatello, S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet. 2013;45(5):546551.
102.Callenbach, PM, van den Maagdenberg, AM, Hottenga, JJ, et al. Familial partial epilepsy with variable foci in a Dutch family: clinical characteristics and confirmation of linkage to chromosome 22q. Epilepsia. 2003;44(10):12981305.
103.International League Against Epilepsy: Engel, J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42(6):796803.
104.Antebi, D, Bird, J. The facilitation and evocation of seizures. Br J Psychiatry. 1992;160:154164.
105.Epilepsy Foundation of America Working Group: Fisher, RS, Harding, G, Erba, G, Barkley, GL, Wilkins, A. Photic- and pattern-induced seizures: a review for the Epilepsy Foundation of America Working Group. Epilepsia. 2005;46(9):14261441.
106.Koepp, MJ, Caciagli, L, Pressler, RM, Lehnertz, K, Beniczky, S. Reflex seizures, traits, and epilepsies: from physiology to pathology. Lancet Neurol. 2016;15(1):92105.
107.Italiano, D, Ferlazzo, E, Gasparini, S, et al. Generalized versus partial reflex seizures: a review. Seizure. 2014;23(7):512520.
108.Verrotti, A, Beccaria, F, Fiori, F, Montagnini, A, Capovilla, G. Photosensitivity: epidemiology, genetics, clinical manifestations, assessment, and management. Epileptic Disord. 2012;14(4):349362.
109.Striano, S, Coppola, A, del Gaudio, L, Striano, P. Reflex seizures and reflex epilepsies: old models for understanding mechanisms of epileptogenesis. Epilepsy Res. 2012;100(1–2):111.
110.Harding, G, Wilkins, AJ, Erba, G, Barkley, GL, Fisher, RS, Epilepsy Foundation of America Working Group. Photic- and pattern-induced seizures: expert consensus of the Epilepsy Foundation of America Working Group. Epilepsia. 2005;46(9):14231425.
111.Hill, RA, Chiappa, KH, Huang-Hellinger, F, Jenkins, BG. Hemodynamic and metabolic aspects of photosensitive epilepsy revealed by functional magnetic resonance imaging and magnetic resonance spectroscopy. Epilepsia. 1999;40(7):912920.
112.Ricci, GB, Chapman, RM, Erne, SN, et al. Neuromagnetic topography of photoconvulsive response in man. Electroencephalogr Clin Neurophysiol. 1990;75(2):112.
113.Kasteleijn-Nolst Trenite, DG, Guerrini, R, Binnie, CD, Genton, P. Visual sensitivity and epilepsy: a proposed terminology and classification for clinical and EEG phenomenology. Epilepsia. 2001;42(5):692701.
114.Ferlazzo, E, Zifkin, BG, Andermann, E, Andermann, F. Cortical triggers in generalized reflex seizures and epilepsies. Brain. 2005;128(Pt 4):700710.
115.Guerrini, R, Genton, P. Epileptic syndromes and visually induced seizures. Epilepsia. 2004;45(Suppl 1):1418.
116.Miller, S, Razvi, S, Russell, A. Reading epilepsy. Pract Neurol. 2010;10(5):278281.
117.Koutroumanidis, M, Koepp, MJ, Richardson, MP, et al. The variants of reading epilepsy. A clinical and video-EEG study of 17 patients with reading-induced seizures. Brain. 1998;121(Pt 8):14091427.
118.Salek-Haddadi, A, Mayer, T, Hamandi, K, et al. Imaging seizure activity: a combined EEG/EMG-fMRI study in reading epilepsy. Epilepsia. 2009;50(2):256264.
119.Stern, J. Musicogenic epilepsy. Handb Clin Neurol. 2015;129:469477.
120.Kaplan, PW. Musicogenic epilepsy and epileptic music: a seizure’s song. Epilepsy Behav. 2003;4(5):464473.
121.Wieser, HG, Hungerbuhler, H, Siegel, AM, Buck, A. Musicogenic epilepsy: review of the literature and case report with ictal single photon emission computed tomography. Epilepsia. 1997;38(2):200207.
122.Avanzini, G. Musicogenic seizures. Ann N Y Acad Sci. 2003;999:95102.
123.Pittau, F, Tinuper, P, Bisulli, F, et al. Videopolygraphic and functional MRI study of musicogenic epilepsy. A case report and literature review. Epilepsy Behav. 2008;13(4):685692.
124.Bebek, N, Gurses, C, Gokyigit, A, et al. Hot water epilepsy: clinical and electrophysiologic findings based on 21 cases. Epilepsia. 2001;42(9):11801184.
125.Satishchandra, P. Hot-water epilepsy. Epilepsia. 2003;44(Suppl 1):2932.
126.Nagaraja, D, Chand, RP. Eating epilepsy. Clin Neurol Neurosurg. 1984;86(2):9599.
127.Loreto, V, Nocerino, C, Striano, P, et al. Eating epilepsy. Heterogeneity of ictal semiology: the role of video-EEG monitoring. Epileptic Disord. 2000;2(2):9398.
128.Aguglia, U, Tinuper, P, Gastaut, H. Startle-induced epileptic seizures. Epilepsia. 1984;25(6):712720.
129.Fernandez, S, Donaire, A, Maestro, I, et al. Functional neuroimaging in startle epilepsy: involvement of a mesial frontoparietal network. Epilepsia. 2011;52(9):17251732.
130.Nolan, MA, Otsubo, H, Iida, K, Minassian, BA. Startle-induced seizures associated with infantile hemiplegia: implication of the supplementary motor area. Epileptic Disord. 2005;7(1):4952.
131.Ricci, S, Cusmai, R, Fusco, L, Vigevano, F. Reflex myoclonic epilepsy in infancy: a new age-dependent idiopathic epileptic syndrome related to startle reaction. Epilepsia. 1995;36(4):342348.
132.Northrup, H, Krueger, DA, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):243254.
133.El-Hattab, AW, Adesina, AM, Jones, J, Scaglia, F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015;116(1–2):412.
134.Middlebrooks, EH, Ver Hoef, L, Szaflarski, JP. Neuroimaging in epilepsy. Curr Neurol Neurosci Rep. 2017;17(4):32.
135.Krumholz, A, Shinnar, S, French, J, Gronseth, G, Wiebe, S. Evidence-based guideline: management of an unprovoked first seizure in adults. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015;85(17):15261527.
136.Gupta, L, Janssens, R, Vlooswijk, MC, et al. Towards prognostic biomarkers from BOLD fluctuations to differentiate a first epileptic seizure from new-onset epilepsy. Epilepsia. 2017;58(3):476483.
137.Semah, F, Picot, MC, Adam, C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 1998;51(5):12561262.
138.Annegers, JF, Hauser, WA, Lee, JR, Rocca, WA. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935–1984. Epilepsia. 1995;36(4):327333.
139.Maschio, M. Brain tumor-related epilepsy. Curr Neuropharmacol. 2012;10(2):124133.
140.Cowie, CJ, Cunningham, MO. Peritumoral epilepsy: relating form and function for surgical success. Epilepsy Behav. 2014;38:5361.
141.Kasper, BS, Kasper, EM. New classification of epilepsy-related neoplasms: the clinical perspective. Epilepsy Behav. 2017;67:9197.
142.Lote, K, Stenwig, AE, Skullerud, K, Hirschberg, H. Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer. 1998;34(1):98102.
143.Ruda, R, Bello, L, Duffau, H, Soffietti, R. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol. 2012;14(Suppl 4):iv55–64.
144.Jooma, R, Yeh, HS, Privitera, MD, Gartner, M. Lesionectomy versus electrophysiologically guided resection for temporal lobe tumors manifesting with complex partial seizures. J Neurosurg. 1995;83(2):231236.
145.van Breemen, MS, Vecht, CJ. Optimal seizure management in brain tumor patients. Curr Neurol Neurosci Rep. 2005;5(3):207213.
146.van Breemen, MS, Wilms, EB, Vecht, CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6(5):421430.
147.Aronica, E, Gorter, JA, Redeker, S, et al. Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy. Neuropathol Appl Neurobiol. 2005;31(3):280291.
148.Chernov, MF, Kubo, O, Hayashi, M, et al. Proton MRS of the peritumoral brain. J Neurol Sci. 2005;228(2):137142.
149.Ivens, S, Kaufer, D, Flores, LP, et al. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain. 2007;130(Pt 2):535547.
150.Chan, CH, Bittar, RG, Davis, GA, Kalnins, RM, Fabinyi, GC. Long-term seizure outcome following surgery for dysembryoplastic neuroepithelial tumor. J Neurosurg. 2006;104(1):6269.
151.Tandon, V, Bansal, S, Chandra, PS, et al. Ganglioglioma: single-institutional experience of 24 cases with review of literature. Asian J Neurosurg. 2016;11(4):407411.
152.Song, JY, Kim, JH, Cho, YH, Kim, CJ, Lee, EJ. Treatment and outcomes for gangliogliomas: a single-center review of 16 patients. Brain Tumor Res Treat. 2014;2(2):4955.
153.Odia, Y. Gangliocytomas and gangliogliomas: review of clinical, pathologic and genetic features. Clin Oncol (Belmont). 2016;1:1017.
154.Xue, H, Sveinsson, O, Tomson, T, Mathiesen, T. Intracranial meningiomas and seizures: a review of the literature. Acta Neurochir (Wien). 2015;157(9):15411548.
155.Lynam, LM, Lyons, MK, Drazkowski, JF, et al. Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg. 2007;109(7):634638.
156.Glantz, MJ, Cole, BF, Forsyth, PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54(10):18861893.
157.Singh, G, Rees, JH, Sander, JW. Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment. J Neurol Neurosurg Psychiatry. 2007;78(4):342349.
158.Patchell, RA, Tibbs, PA, Walsh, JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990;322(8):494500.
159.Chadehumbe, MA, Khatri, P, Khoury, JC, et al. Seizures are common in the acute setting of childhood stroke: a population-based study. J Child Neurol. 2009;24(1):912.
160.Szaflarski, JP, Rackley, AY, Kleindorfer, DO, et al. Incidence of seizures in the acute phase of stroke: a population-based study. Epilepsia. 2008;49(6):974981.
161.Ferlazzo, E, Gasparini, S, Beghi, E, et al. Epilepsy in cerebrovascular diseases: review of experimental and clinical data with meta-analysis of risk factors. Epilepsia. 2016;57(8):12051214.
162.Silverstein, FS, Barks, JD, Hagan, P, et al. Cytokines and perinatal brain injury. Neurochem Int. 1997;30(4–5):375383.
163.Fitzgerald, KC, Williams, LS, Garg, BP, Golomb, MR. Epilepsy in children with delayed presentation of perinatal stroke. J Child Neurol. 2007;22(11):12741280.
164.Rosenbaum, P, Paneth, N, Leviton, A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109:814.
165.Golomb, MR, Garg, BP, Carvalho, KS, Johnson, CS, Williams, LS. Perinatal stroke and the risk of developing childhood epilepsy. J Pediatr. 2007;151(4):409413.
166.Krageloh-Mann, I, Cans, C. Cerebral palsy update. Brain Dev. 2009;31(7):537544.
167.Vannucci, RC. Hypoxic-ischemic encephalopathy. Am J Perinatol. 2000;17(3):113120.
168.Laptook, AR, Shankaran, S, Ambalavanan, N, et al. Outcome of term infants using apgar scores at 10 minutes following hypoxic-ischemic encephalopathy. Pediatrics. 2009;124(6):16191626.
169.Tagin, MA, Woolcott, CG, Vincer, MJ, Whyte, RK, Stinson, DA. Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis. Arch Pediatr Adolesc Med. 2012;166(6):558566.
170.Ekert, P, Perlman, M, Steinlin, M, Hao, Y. Predicting the outcome of postasphyxial hypoxic-ischemic encephalopathy within 4 hours of birth. J Pediatr. 1997;131(4):613617.
171.Spitzmiller, RE, Phillips, T, Meinzen-Derr, J, Hoath, SB. Amplitude-integrated EEG is useful in predicting neurodevelopmental outcome in full-term infants with hypoxic-ischemic encephalopathy: a meta-analysis. J Child Neurol. 2007;22(9):10691078.
172.Carlsson, M, Hagberg, G, Olsson, I. Clinical and aetiological aspects of epilepsy in children with cerebral palsy. Dev Med Child Neurol. 2003;45(6):371376.
173.Kilpatrick, CJ, Davis, SM, Hopper, JL, Rossiter, SC. Early seizures after acute stroke. Risk of late seizures. Arch Neurol. 1992;49(5):509511.
174.So, EL, Annegers, JF, Hauser, WA, O’Brien, PC, Whisnant, JP. Population-based study of seizure disorders after cerebral infarction. Neurology. 1996;46(2):350355.
175.Silverman, IE, Restrepo, L, Mathews, GC. Poststroke seizures. Arch Neurol. 2002;59(2):195201.
176.Koopman, WJ, Willems, PH, Smeitink, JA. Monogenic mitochondrial disorders. N Engl J Med. 2012;366(12):11321141.
177.Chinnery, PF. Mitochondrial disorders overview. In: Adam, MP, Ardinger, HH, Pagon, RA, et al., eds., GeneReviews(R). Seattle, WA: University of Washington; 2000.
178.Schon, EA, Bonilla, E, DiMauro, S. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr. 1997;29(2):131149.
179.Taylor, RW, Chinnery, PF, Clark, KM, Lightowlers, RN, Turnbull, DM. Treatment of mitochondrial disease. J Bioenerg Biomembr. 1997;29(2):195205.
180.Baertling, F, Rodenburg, RJ, Schaper, J, et al. A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry. 2014;85(3):257265.
181.Leigh, PN, Al-Sarraj, S, DiMauro, S. Impact commentaries. Subacute necrotising encephalomyelopathy (Leigh’s disease; Leigh syndrome). J Neurol Neurosurg Psychiatry. 2015;86(4):363365.
182.Milone, M, Massie, R. Polymerase gamma 1 mutations: clinical correlations. Neurologist. 2010;16(2):8491.
183.Saneto, RP, Cohen, BH, Copeland, WC, Naviaux, RK. Alpers-Huttenlocher syndrome. Pediatr Neurol. 2013;48(3):167178.
184.Barkovich, AJ, Kuzniecky, RI, Jackson, GD, Guerrini, R, Dobyns, WB. A developmental and genetic classification for malformations of cortical development. Neurology. 2005;65(12):18731887.
185.Barkovich, AJ, Dobyns, WB, Guerrini, R. Malformations of cortical development and epilepsy. Cold Spring Harb Perspect Med. 2015;5(5):a022392.
186.Tinkle, BT, Schorry, EK, Franz, DN, Crone, KR, Saal, HM. Epidemiology of hemimegalencephaly: a case series and review. Am J Med Genet A. 2005;139(3):204211.
187.Leventer, RJ, Phelan, EM, Coleman, LT, et al. Clinical and imaging features of cortical malformations in childhood. Neurology. 1999;53(4):715722.
188.Blumcke, I, Thom, M, Aronica, E, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011;52(1):158-174.
189.Hauptman, JS, Mathern, GW. Surgical treatment of epilepsy associated with cortical dysplasia: 2012 update. Epilepsia. 2012;53(Suppl 4):98104.
190.Aghakhani, Y, Kinay, D, Gotman, J, et al. The role of periventricular nodular heterotopia in epileptogenesis. Brain. 2005;128(Pt 3):641651.
191.Sheen, VL, Dixon, PH, Fox, JW, et al. Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet. 2001;10(17):17751783.
192.Eksioglu, YZ, Scheffer, IE, Cardenas, P, et al. Periventricular heterotopia: an X-linked dominant epilepsy locus causing aberrant cerebral cortical development. Neuron. 1996;16(1):7787.
193.Granata, T, Freri, E, Caccia, C, et al. Schizencephaly: clinical spectrum, epilepsy, and pathogenesis. J Child Neurol. 2005;20(4):313318.
194.Dobyns, WB, Reiner, O, Carrozzo, R, Ledbetter, DH. Lissencephaly. A human brain malformation associated with deletion of the LIS1 gene located at chromosome 17p13. JAMA. 1993;270(23):28382842.
195.Leventer, RJ. Genotype-phenotype correlation in lissencephaly and subcortical band heterotopia: the key questions answered. J Child Neurol. 2005;20(4):307312.
196.Devisme, L, Bouchet, C, Gonzales, M, et al. Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies. Brain. 2012;135(Pt 2):469482.
197.D’Agostino, MD, Bernasconi, A, Das, S, et al. Subcortical band heterotopia (SBH) in males: clinical, imaging and genetic findings in comparison with females. Brain. 2002;125(Pt 11):25072522.
198.Mai, R, Tassi, L, Cossu, M, et al. A neuropathological, stereo-EEG, and MRI study of subcortical band heterotopia. Neurology. 2003;60(11):18341838.
199.Leventer, RJ, Jansen, A, Pilz, DT, et al. Clinical and imaging heterogeneity of polymicrogyria: a study of 328 patients. Brain. 2010;133(Pt 5):14151427.
200.Napolioni, V, Curatolo, P. Genetics and molecular biology of tuberous sclerosis complex. Curr Genomics. 2008;9(7):475487.
201.Korf, BR, Bebin, EM. Neurocutaneous disorders in children. Pediatr Rev. 2017;38(3):119128.
202.Wu, JY, Peters, JM, Goyal, M, et al. Clinical electroencephalographic biomarker for impending epilepsy in asymptomatic tuberous sclerosis complex infants. Pediatr Neurol. 2016;54:2934.
203.Comi, AM. Sturge-Weber syndrome and epilepsy: an argument for aggressive seizure management in these patients. Expert Rev Neurother. 2007;7(8):951956.
204.Assogba, K, Ferlazzo, E, Striano, P, et al. Heterogeneous seizure manifestations in Hypomelanosis of Ito: report of four new cases and review of the literature. Neurol Sci. 2010;31(1):916.
205.Hubert, JN, Callen, JP. Incontinentia pigmenti presenting as seizures. Pediatr Dermatol. 2002;19(6):550552.
206.Ostendorf, AP, Gutmann, DH, Weisenberg, JL. Epilepsy in individuals with neurofibromatosis type 1. Epilepsia. 2013;54(10):18101814.
207.Drouet, A. [Seizures in neurofibromatosis. What is the risk?]. Rev Neurol (Paris). 2011;167(12):886896.
208.Temkin, NR. Preventing and treating posttraumatic seizures: the human experience. Epilepsia. 2009;50(Suppl 2):1013.
209.Szaflarski, JP. Is there equipoise between phenytoin and levetiracetam for seizure prevention in traumatic brain injury? Epilepsy Curr. 2015;15(2):9497.
210.Szaflarski, JP, Nazzal, Y, Dreer, LE. Post-traumatic epilepsy: current and emerging treatment options. Neuropsychiatr Dis Treat. 2014;10:14691477.
211.Annegers, JF, Hauser, WA, Coan, SP, Rocca, WA. A population-based study of seizures after traumatic brain injuries. N Engl J Med. 1998;338(1):2024.
212.Asikainen, I, Kaste, M, Sarna, S. Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia. 1999;40(5):584589.
213.Annegers, JF, Grabow, JD, Groover, RV, et al. Seizures after head trauma: a population study. Neurology. 1980;30(7 Pt 1):683689.
214.Ritter, AC, Wagner, AK, Fabio, A, et al. Incidence and risk factors of posttraumatic seizures following traumatic brain injury: a Traumatic Brain Injury Model Systems Study. Epilepsia. 2016;57(12):19681977.
215.Ritter, AC, Wagner, AK, Szaflarski, JP, et al. Prognostic models for predicting posttraumatic seizures during acute hospitalization, and at 1 and 2 years following traumatic brain injury. Epilepsia. 2016;57(9):15031514.
216.Chang, B, Lowenstein, D. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury. Neurology. 2003;60(1):1016.
217.Szaflarski, JP, Sangha, KS, Lindsell, CJ, Shutter, LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care. 2010;12(2):165172.
218.Taylor, S, Heinrichs, RJ, Janzen, JM, Ehtisham, A. Levetiracetam is associated with improved cognitive outcome for patients with intracranial hemorrhage. Neurocrit Care. 2011;15(1):8084.
219.Turjman, F, Massoud, TF, Sayre, JW, et al. Epilepsy associated with cerebral arteriovenous malformations: a multivariate analysis of angioarchitectural characteristics. Am J Neuroradiol. 1995;16(2):345350.
220.Crawford, PM, West, CR, Chadwick, DW, Shaw, MD. Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry. 1986;49(1):110.
221.Rosenow, F, Alonso-Vanegas, MA, Baumgartner, C, et al. Cavernoma-related epilepsy: review and recommendations for management – report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2013;54(12):20252035.
222.Josephson, CB, Leach, JP, Duncan, R, et al. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology. 2011;76(18):15481554.
223.Striano, S, Nocerino, C, Striano, P, et al. Venous angiomas and epilepsy. Neurol Sci. 2000;21(3):151155.
224.Mills, PB, Footitt, EJ, Mills, KA, et al. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency). Brain. 2010;133(Pt 7):21482159.
225.Wang, D, Pascual, JM, De Vivo, D. Glucose transporter type 1 deficiency syndrome. In: Adam, MP, Ardinger, HH, Pagon, RA, et al., eds. GeneReviews®, Seattle, WA: University of Washington; 2002.
226.Annegers, JF, Rocca, WA, Hauser, WA. Causes of epilepsy: contributions of the Rochester epidemiology project. Mayo Clin Proc. 1996;71(6):570575.
227.Khan, NA, Kazzi, SN. Yield and costs of screening growth-retarded infants for torch infections. Am J Perinatol. 2000;17(3):131135.
228.Misra, UK, Tan, CT, Kalita, J. Viral encephalitis and epilepsy. Epilepsia. 2008;49(Suppl 6):1318.
229.Annegers, JF, Hauser, WA, Beghi, E, Nicolosi, A, Kurland, LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. 1988;38(9):14071410.
230.Chuang, MJ, Chang, WN, Chang, HW, et al. Predictors and long-term outcome of seizures after bacterial brain abscess. J Neurol Neurosurg Psychiatry. 2010;81(8):913917.
231.Granerod, J, Ambrose, HE, Davies, NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10(12):835844.
232.Burneo, JG, Cavazos, JE. Neurocysticercosis and epilepsy. Epilepsy Curr. 2014;14(1 Suppl):2328.
233.Baird, RA, Wiebe, S, Zunt, JR, et al. Evidence-based guideline: treatment of parenchymal neurocysticercosis. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;80(15):14241429.
234.Khawaja, AM, DeWolfe, JL, Miller, DW, Szaflarski, JP. New-onset refractory status epilepticus (NORSE) – the potential role for immunotherapy. Epilepsy Behav. 2015;47:1723.
235.Vezzani, A, French, J, Bartfai, T, Baram, TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011;7(1):3140.
236.Vezzani, A, Friedman, A. Brain inflammation as a biomarker in epilepsy. Biomark Med. 2011;5(5):607614.
237.Kivity, S, Agmon-Levin, N, Zandman-Goddard, G, Chapman, J, Shoenfeld, Y. Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med. 2015;13:43.
238.Joseph, FG, Scolding, NJ. Cerebral vasculitis: a practical approach. Practical Neurology. 2002;2(2):8093.
239.Krumholz, A, Stern, BJ, Stern, EG. Clinical implications of seizures in neurosarcoidosis. Arch Neurol. 1991;48(8):842844.